BCM
IRWD icon

Bridgeway Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bridgeway Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
389,793
-50,700
-12% -$195K 0.03% 622
2026
Q1 		$1.55M Sell
440,493
-55,500
-11% -$227K 0.03% 596
2025
Q4 		$1.67M Buy
495,993
+345,993
+231% +$899K 0.04% 585
2025
Q3 		$197K Buy
150,000
+75,000
+100% +$77.6K ﹤0.01% 1016
2025
Q2 		$53.8K Buy
75,000
+44,000
+142% +$34.5K ﹤0.01% 1132
2025
Q1 		$45.6K Hold
31,000
– – ﹤0.01% 1125
2024
Q4 		$137K Sell
31,000
-280,200
-90% -$1.14M ﹤0.01% 1066
2024
Q3 		$1.28M Hold
311,200
– – 0.03% 617
2024
Q2 		$2.03M Sell
311,200
-16,800
-5% -$119K 0.05% 509
2024
Q1 		$2.86M Buy
+328,000
New +$3.98M 0.06% 463

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bridgeway Capital Management's IRWD Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 12% in Q2 2026, selling an estimated $195K and leaving 389,793 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #622.

Bridgeway Capital Management first reported a position in IRWD in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.86M in Q1 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Bridgeway Capital Management held 389,793 shares of Ironwood Pharmaceuticals worth $1.64M as of Q2 2026.
  • Bridgeway Capital Management sold 50,700 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $195K.
  • Ironwood Pharmaceuticals made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #622 holding.
  • Bridgeway Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Bridgeway Capital Management's Ironwood Pharmaceuticals position peaked at $2.86M in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.